Buprenorphine Side Effects Can Cause Tooth Decay, Other Dental Problems, FDA Warns

Federal drug regulators are warning about potential side effects of buprenorphine, indicating that the drug often prescribed to combat opioid addiction may cause tooth decay, infection, and other dental issues.

Medications containing buprenorphine designed to dissolve in the mouth can lead to dental problems, according to a drug safety communication issued by the FDA on January 12. Users with no history of dental issues have reported experiencing tooth decay, cavities, oral infections and loss of teeth, the agency warns.

Buprenorphine was first approved in 2002, as a tablet to be taken under the tongue to treat opioid addiction. In 2015, buprenorphine was approved as a film to be placed inside the cheek to treat pain. Other studies have linked buprenorphine as the best drug to treat neonatal abstinence, among infants born addicted to narcotic painkillers. However, the FDA indicates there have been more than 300 cases of tooth decay and dental problems reported among patients, most commonly involving tooth decay among users in their 40s, but dental problems have also been seen among those as young as 18 years old. Some dental problems from buprenorphine occurred as soon as two weeks after beginning treatment.

While the FDA indicates it believes the benefits of buprenorphine still outweigh the risks, the agency is requiring a new warning be added to the prescribing information and the patient Medication Guide for all buprenorphine-containing medicines dissolved in the mouth.

Medications affected by the warning include Zubsolv, manufactured by Orexo, and Suboclade manufactured by Indivior. They are tablets and films which dissolve under the tongue or placed against the inside of the cheek.

Suboxone Lawsuits Over Tooth Decay and Tooth Loss
Suboxone Lawsuits Over Tooth Decay and Tooth Loss

For patients taking buprenorphine drugs affected by the warning, the FDA recommends continuing to take the medication as prescribed and not stopping the medication until you speak to your doctor first. Suddenly stopping the treatment could lead to serious consequences, including withdrawal symptoms or opioid relapse, which can result in an overdose and death.

Patients using the medication to treat opioid use disorder can take extra steps to reduce the risk of dental problems, the FDA indicates.

The agency recommends patients take a large sip of water, swish it gently and swallow once the medication is completely dissolved in the mouth. They should then wait at least one hour before brushing their teeth to avoid damage and to give their mouth a chance to return to its natural state, the FDA warning indicates.

The FDA also recommends patients inform their doctor if they have a history of tooth problems, including cavities, when starting this medication. They should also schedule a visit with their dentist soon after starting to use this drug and inform their dentist they are taking buprenorphine. Patients taking the drug should also make sure to have regular dental checkups while taking buprenorphine and to notify their doctor and dentist immediately if they experience problems with their teeth and gums.

September 2023 Suboxone Tooth Decay Lawsuit Update

Following the FDA update, which has come far too late for many, a growing number of individuals are now pursuing Suboxone tooth decay lawsuits claiming that Indivior Inc. and its affiliated businesses failed to adequately research the Suboxone sublingual film dental problems before offering it to the market.

Medical research and hundreds of adverse events have now linked Suboxone films to an increased risk of users with no previous history of dental issues now experiencing tooth decay, cavities, oral infections, gum disease and loss of teeth, often requiring extensive dental care.

Lawsuits claim that the manufacturer placed its market position and profits above consumer safety, which has now caused users to experience dental problems that were not originally disclosed.

Who can file a Suboxone lawsuit over tooth decay side effects?

Lawyers across the nation are now investigating Suboxone lawsuits for individuals who used buprenorphine and naloxone sublingual films, and suffered any of the following complications:

  • Severe tooth decay
  • Tooth loss
  • Broken teeth
  • Tooth extractions
  • Underwent oral surgery
  • Required dental implants
  • Other serious tooth issues



152 Comments


Carolyn
I have lost 4 teeth and I am losing more as a result of using Subutex My prescribing doctor just told my about the potential of losing teeth as a result of using Subutex in February 2022. People should have been warned of this side effect as I would have tried another medication. Thank you for your time

Robin
Over a span of 2 years, I have lost 3 healthy teeth as a result of taking Suboxone. I was never warned about tooth loss. After researching this issue, I have learned that Suboxone weakens the bones around the teeth, thereby loosening the teeth, and they fall out. I have been unable to stop using this drug because the withdrawal is excruciating. The cost of fixing my teeth is in the tens of thousands of dollars. The makers of this drug should be held accountable for this harm.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

A federal judge wants lawyers involved in hair relaxer lawsuits to provide an update this week on the status of discovery proceedings for a pool of cases being considered for bellwether trial dates.
Two Covidien Parietex Optimized Composite hernia mesh lawsuits have been chosen to be prepared to potentially serve as the third Covidien hernia mesh bellwether trial.
Six women have filed a joint, multiplaintiff BioZorb tissue marker lawsuit, all indicating that they suffered injuries and complications due to the recalled device’s defective design.